Tissue microenvironment cellular receptors

Tissue microenvironment cellular receptors encompass a broad and heterogeneous collection of cell-surface proteins located on various cell types within a tissue's local milieu, including immune cells, fibroblasts, and endothelial cells (Anderson & Simon, 2020). These receptors are critical for sensing and responding to external stimuli, such as growth factors, cytokines, and extracellular matrix components, thereby regulating cellular behavior and tissue homeostasis (Hanahan, 2022). In the context of disease, particularly oncology, these receptors—such as PD-1, CTLA-4, and VEGFR—are frequently exploited by tumors to evade immune detection or promote vascularization (Binnewies et al., 2018). Therapeutic strategies targeting these receptors include monoclonal antibodies and small molecule inhibitors designed to disrupt pathological signaling or reactivate the host immune response. Because this term refers to a functional category of diverse molecular entities rather than a single specific protein, it is considered a collective classification in drug development and clinical research. Understanding the collective behavior of these receptors is essential for developing combinatorial therapies that address the complexity of the tissue microenvironment. This category includes well-known targets like immune checkpoints, chemokine receptors, and growth factor receptors that define the interaction between a tumor and its surrounding stroma.

Other names

TME receptorsTumor microenvironment receptorsStromal cell surface receptorsMicroenvironmental signaling receptors

Modulation of the tissue microenvironment through the inhibition or activation of specific cell-surface receptors on immune, stromal, or endothelial cells to disrupt disease progression.